Clinical evidence

VenCoM.01 study

  • Study Start Date: 26 January 2023
  • Study Completion Date: 31 December 2024
  • Status: recruitment completed (enrolled 70 patients)
  • Sponsor: Tre Esse Progettazione Biomedica s.r.l.
  • Clinical Study Centre: Cardiac Insufficiency and Transplantation Unit, IRCCS – Azienda Ospedaliero-Universitaria of Bologna
  • Primary Endpoint: to verify the concordance between non-invasive VenCoM measurement and invasive CVP measurement via catheterization (clinical gold standard)
  • Secondary Endpoint: to evaluate correlations between non-invasive VenCoM measurements and standard ultrasound-based measurements
VenCoM system in use: the cuffs placed around the patient's arm
Back to top